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ABSTRACT
Introduction: Since 1978, Rohingya refugees have fled from their native nation, Myanmar to escape ethnic prose-
cution. They comprise of the Muslim minority ethnic group originating from the Rakhine state in Myanmar. In many 
host countries, they may have difficulty to access health care services. The Islamic Association of Malaysia (IMAM) 
Response and Relief Team (IMARET) have taken many initiatives to provide healthcare services to the refugees 
through their volunteer-led mobile clinics. Therefore, this study aims to evaluate the utilisation of drugs among type 
2 diabetes mellitus (T2DM) patients visiting this clinic. Methods: This was a cross-sectional study among Rohingya 
refugees with T2DM that visited the IMARET mobile clinics from August until November 2017. Convenient sampling 
method was used. Data were collected through patient’s interview, review of the patient’s prescriptions and their 
HbA1c readings. Results: A total of 29 T2DM patients were included in this study. The majority were female (75.9%) 
and aged below 65 years old (75.9%). The most commonly prescribed anti-diabetic agent was metformin (72.2%), 
followed by glibenclamide (22.2%) and gliclazide (5.6%). Metformin as a monotherapy (31%) was the most frequent 
treatment prescribed. More patients had controlled T2DM (62.1%) compared to those with uncontrolled DM. We 
found 90.9% of patients who were treated according to the recommended DM guidelines achieved a good blood 
glucose control (p=0.02). Conclusion: In Rohingya refugees having T2DM who were treated in the IMARET mobile 
clinic, the percentage having good control DM status is higher in those whose treatment regimen adheres to the 
clinical practice guidelines.
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INTRODUCTION
The Rohingyas are a Muslim ethnic minority group 
originating from the Rakhine state in Myanmar, which 
borders with Bangladesh on the north and the Bay of 
Bengal on the west. In 1978, ethnic prosecution forced 
more than 200 000 Rohingyas to flee to the neighbouring 
state of Bangladesh. By 2012, the conflict reached its 
climax with frequent occurrence of violent clashes 
between the Rohingya and Rakhine population causing 
another 140 000 Rohingya to flee to internally displaced 
person (IDP) camps. Since then, the Rohingyas have 
also fled to other Asian countries, namely Bangladesh, 
Thailand and Malaysia (1). As of January 2017, 56 135 
Rohingyas have been registered with United Nations 
High Commissioner for Refugees (UNHCR) in Malaysia. 
The Rohingyas are at risk of poor health and nutritional 
status due to their lack of education and employment 
opportunities as well as access to health care services. 
The barriers in accessing health care services are mainly 
contributed by high medical costs and also major 
problem in terms of language barrier (2).
Type 2 diabetes mellitus (T2DM) remains a major public 
health concern worldwide and is associated with severe 
microvascular and macrovascular complications. Based 
on IMARET’s medical records over the previous years, 
there were 56 cases of DM that were detected among the 
1402 Rohingya refugee patients that visited the mobile 
clinic from the period of September 2015 to December 
2016. Due to the many problems that directly inhibit 
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access to quality healthcare services, refugees therefore 
become hesitant to seek the required medical help, 
hence they are at higher risk of developing the severe 
complications from their medical conditions (2). Hence, 
this may lead to more severe diabetic complications in 
this community.
IMAM Response & Relief Team better, known as 
IMARET is a chapter by the Islamic Medical Association 
of Malaysia (IMAM). IMARET’s main aim is to provide 
high quality healthcare services and promotional 
activities to those in need of these essential services. 
Among the activities done by IMARET is providing 
emergency health care relief to those involved in natural 
or man-made disaster such as the recent Malaysian East 
Coast flood relief and Sulawesi Tsunami relief. IMARET 
not only reaches out to those in need in Malaysia but 
are also active internationally by involvement in major 
volunteering activities such as in Cox Bazaar which 
is located in Bangladesh itself, primarily to assist the 
Rohingya refugee community there through health 
check-ups. IMARET is also involved in running many 
mobile clinics for other marginalised communities 
in Malaysia such as the Orang Asli and Bajau Laut 
communities.  This is in addition to the mobile clinics 
that are dedicated to the Rohingya refugees in Malaysia. 
IMARET members include both Muslims and non-
Muslims who are either healthcare or healthcare related 
professionals and students.  The mobile clinics are held 
once every fortnight or month, depending the number 
of personnels available to man the clinic. IMARET will 
prepare the equipments, medications, and also organise 
the volunteers’ pools to both set up and run the clinic 
which is usually held on Sundays. 
The clinics are usually set up at places that are easily 
accessible to the Rohingya community in Malaysia. The 
leaders of the community will be advised on the location 
the clinics beforehand and will then be tasked with 
spreading the word among their social contacts. Funding 
of these clinics are by generous donations from corporate 
sponsors and the general public. All medications are 
kept in a warehouse, carefully supervised by IMARET. 
Drug Utilisation Evaluation (DUE) also known as drug 
utilisation review (DUR) or medication utilisation 
evaluation (MUE), is defined as an authorised, structured, 
and ongoing review of healthcare providers’ prescribing 
pattern, pharmacists’ dispensing pattern and patients’ 
use of medication. This is basically a broad evaluation 
of patient’s medication and prescription information 
before, during and after dispensing. This is done to 
ensure that accurate decision making steps and desired 
patient outcomes are achieved (3). Prior to this study, no 
evaluation of the treatment prescribed to refugees with 
T2DM were done. Specifically, for this IMARET mobile 
clinic, DUE/MUE is done for the following purposes: 1) 
for procurement of pharmaceutical drugs 2) to evaluate 
the efficiency of administrative process of the day to 
day clinic operation 3) as part of an internal audit for 
improving the service delivery to the refugees and 4) to 
report of usage of fund to the stakeholders / donors.
 
This study was conducted to evaluate the utilisation 
of drugs among Rohingya refugees with T2DM 
, characterised by the drug prescribing pattern, 
appropriateness of anti-diabetic regimens prescribed, 
and an analysis of clinical and sociodemographic profile 
of the refugees with diabetes.
MATERIALS AND METHODS
This was a cross-sectional study conducted among the 
Rohingya refugees who presented to the mobile clinics 
with T2DM from the month of August until November 
2017. IMARET mobile clinics are strategically located at 
the districts of Selayang, Seri Kembangan and Ampang 
in Malaysia. Data was collected via patient interview, 
review of their prescriptions, and by conducting the 
HbA1c test. Convenient sampling method was used in 
this study as the sample for this study depends on how 
many T2DM patients visited the mobile clinic during the 
period of study. 
Patients attending the clinic will initially be registered 
at the registration counter, where they will be screened 
for eligibility to participate in the study. The inclusion 
criteria are patients that have evidence of previously 
diagnosed T2DM, such as having a referral letter 
from another clinic coupled with anti-diabetic drug(s) 
prescription or through diagnosis made during previous 
IMARET mobile clinics. We excluded those that are 
below 18 years old, the newly diagnosed and those that 
refuse testing for capillary blood glucose and HbA1c test 
for determining the latest blood glucose level . Once they 
have fulfilled the inclusion criteria, they will be recruited 
into the study and briefed on the major objectives and 
steps involved in the study which also would include 
analysis of their blood glucose control. The blood tests 
are usually done as soon as the patient is registered, and 
when the results are available, they will then proceed to 
have consultation with the volunteer doctor. The doctor 
will then manage the patient accordingly. The decision 
to treat and manage the individual patient is based on 
the clinical evaluation and expertise of the treating 
doctor.  The patient will then proceed to the  dispensary 
to refill their prescription.  Follow ups will normally be 
arranged in a month due to the limitation of medication 
supply, unless there are no clinic organised due to 
unforeseen circumstances, which include raids done by 
the enforcement team such as those from immigration 
officers. 
The interview of the participants were usually done by 
trained researchers while the participants await their 
blood results. The researchers will use the help of trained 
translators to ask the relevant questions in those who 
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have problems communicating in Malay or English. The 
translators are trained Rohingya refugees who had basic 
education in the Pelangi Kasih School conducted by the 
non- governmental organisation, Human Aid, where 
they were also taught to speak both these languages. 
The patients’ socio-demographic data were analysed 
along with their HbA1c and glucometer readings. Based 
on the socio demographic and clinical data, patient’s 
target HbA1c were determined based on the Malaysian 
T2DM Clinical Practice Guideline (CPG) 2015 (12).  This 
guideline was adapted from the position statement of the 
American Diabetes Association (ADA) and the European 
Association for the Study of Diabetes (EASD) in 2012 
(7, 12).  This committee incorporated several factors 
that determined the specific goals for blood glucose 
control such as the patient’s age, time since diagnosis, 
and the presence of comorbidities (10).  Besides that, 
the current treatment regimen that the patients were 
receiving, were also compared to the one detailed in the 
Malaysian CPG. According to this important guideline, 
the blood glucose level and/or the HbA1c level of the 
patient will determine the type of treatment that they 
should  received. 
Tools
1. A structured data collection form was designed 
to capture the data. The data collection form was 
developed by the researchers based on the Malaysian 
Clinical Practice Guidelines on Management of Type 
2 DM 2015 which were as the main guide. The data 
collection form consists of four main sections which are:
Section 1: Demographic details
Section 2: Clinical background that includes 
measurements of body mass index (BMI), blood pressure 
and blood glucose levels. The random or fasting capillary 
blood glucose measurements are taken as normal flow 
of diabetic clinic, but the results are not analysed in this 
study. 
Section 3: Type of therapy received, and the anti-
diabetic agent prescribed
Section 4: Documentation of DM control status based 
on the HbA1c target
2. Point of care HbA1c device
This machine analyses patient’s HbA1c level via finger 
prick testing and has been approved by the US Food 
and Drug Association as a validated HbA1c monitoring 
device. It has been shown to have good specificity and 
sensitivity. However, compared to laboratory results, 
it has been shown to be less accurate in reporting the 
HbA1c level (11). 
Data collected were analysed using Statistical Package 
for the Social Sciences (SPSS) software version 23.0. 
The socio demographic data, clinical characteristics of 
the participants and analysis of their prescriptions were 
reported using descriptive statistics. The association 
between the treatment regimen prescribed according 
to the local guidelines with the overall diabetic control 
and the correlations between BMI with age and HbA1c 
levels were determined using the Fisher’s exact test and 
Pearson’s correlation tests, respectively. The level of 
statistical significance was set at p<0.05.
Ethical approval was obtained from Cyberjaya University 
College of Medical Sciences (CUCMS) Research Ethics 
Review Committee (CRERC)[reference number: CUCMS/
CRERC/FR/013].
RESULTS  
Demographic Data & Clinical characteristics
Table I shows the demographic data and clinical 
characteristics of the participants. A total of 39 
patients who attended the IMARET mobile clinic from 
August until November were screened for inclusion 
and exclusion criteria for recruitment into this study. 
However, only 29 patients were included in this study 
and the remaining 10 was excluded due to not meeting 
the criteria outlined. The majority of the patients with 
T2DM at the mobile clinic were aged below 65 (22, 
75.9%) with a mean age of 50.9 ±12.2 years. Most of 
the patients were female (22, 75.9%). The majority of 
the T2DM patients were obese (17, 58.6%) with only 
four participants (13.8%) being of normal weight. 
Table I: Demographic Data and Clinical Characteristics of Patients 
Characteristic Frequency (%)
(N = 29)
Range Mean (SD)
Age (32-75) 50.9 (12.2)
Below 65 years old 22 (75.9)
65 years and above 7 (24.1)
Gender
Male 7 (24.1)
Female  22 (75.9)
HbA1c control (%) (4.8 - 10.4) 7.4 (1.7)
< 6.5% 9 (31)
6.5 - < 7.5% 7 (24.1)
7.5 - < 8.5% 3 (10.3)
8.5 - < 10% 7 (24.1)
>10% 3 (10.3)
Blood Pressure (mmHg)
Systolic (102- 189) 139.2 (21.7)
Diastolic (37- 116) 86.3 (15.9)
BMI (kg/m2) (17.9- 
43.3)
27.5 (6.1)
Underweight ( < 18.5) 2 (6.9)
Normal ( 18.5 - 22.9 ) 4 (13.8)
Overweight ( 23- 27.4) 6 (20.7)
Obese (≥27.5) 17(58.6)
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Prescribing patterns of T2DM patients in IMARET 
Mobile Clinic
The anti-diabetic agents prescribed in this clinic are 
shown in Table II. Metformin was the most frequently 
prescribed oral anti-diabetic drug and is used either as a 
monotherapy or as a combination therapy. The majority 
of the patients were on lifestyle therapy (15, 51.7%) as 
compared to 14 patients that were either on monotherapy 
or combination therapy involving biguanides (metformin) 
or suphonylureas (glibenclamide, gliclazide).  
Table II: Anti-diabetic Agents’ Prescription Patterns
Treatment Frequency (%)
(N=29)
No treatment (lifestyle approach) 15 (51.7)
Monotherapy
Metformin 9 (31)
Glibenclamide 1(3.4)
Combination
Metformin + glibenclamide 3(10.3)
Metformin + gliclazide 1 (3.4)
Table III shows the type of therapy the participants 
are receiving based on the glycemic control of the 
participant. Patients who have good control of their 
HbA1c levels were mostly on diet modification (7, 
24.1%), while for all 3 patients with HbA1c of >10%, 
they were only on a single oral anti diabetic drug (OAD). 
The patients were later categorized according to the 
recommended target glycemic control based on their 
co-morbid medical conditions. Table IV illustrates the 
target HbA1c for each patient based on the Malaysian 
CPG T2DM guidelines 2015. Each patient has been 
categorised based on their sociodemographic and co 
morbidities data to their targeted HbA1c. Out of the 9 
patients that had a target HbA1c level of 6.0-6.5, only 
5 of them reached this target. The other 4 patients did 
not achieve this target glycemic control level. Overall, 
majority of the patients reached the target HbA1c 
levels (18, 68.1%).  Table V shows the compliance to 
treatment recommendation by physicians based on 
patient’s HbAIc levels. Only 44.8 % of the physicians 
followed the recommended prescription guidelines with 
none of them complying with the treatment guidelines 
when the HbA1c level exceeds 8.5%. Table VI shows 
the association between the treatment plan of T2DM 
patients in the mobile clinic with their diabetic control. 
This association was significant (p=0.02) with 92.3% of 
patients treated according to the recommendations and 
having a good glycemic control. Table VII shows the 
correlation between HbAIc control with age and BMI; 
however, both these correlations were not significant. 
 
DISCUSSION
This study was done in a volunteer-based mobile clinic 
in which the main aim of this clinic was to help the 
Rohingya refugee community residing in Malaysia 
obtain quality medical care. The volunteers are mainly 
Table III: Type of Therapy Prescribed Based on Glycemic Control
Glycemic 
control (%)
Type of therapy (N = 29)
No treatment (life-
style approach)
OAD monotherapy
Dual combina-
tion therapy
<6.5 7 (24.1) 2 (6.9) 0 (0)
6.5- <7.5 4 (13.8) 3 (10.3) 0 (0)
7.5- <8.5 1 (3.4) 1 (3.4) 1 (3.4)
8.5- 10 3 (10.3) 1 (3.4) 3 (10.3)
>10 0 (0) 3 (10.3) 0 (0)
OAD= oral anti diabetic
Table IV: Target Glycaemic Control based on the Malaysian CPG 
Recommendation
Target HbA1c  
(%)
DM control (N= 29)
yes no Total
Frequency (%) Frequency (%) Frequency (%)
6.0-6.5 5 (17.2) 4 (13.8) 9 (31.0)
6.6-7.0 5 (17.2) 4 (13.8) 9 (31.0)
7.1-8.0 8 (20.7) 3 (17.2) 11(37.9)
Total        18 (62.1) 11 (37.9)
CPG= Clinical Practice guidelines
Table V: Prescribing Habits in the IMARET Mobile Clinic Compared 
to the Malaysian CPG 
HbA1C (%) Treatment recommendations
Prescription following rec-
ommendation (N= 29)
Yes (%) No (%)
< 6.5
No treatment given
(lifestyle approach)
9 (31.0) 0 (0)
6.5-<7.5 OAD monotherapy 3 (10.3) 4 (13.8)
7.5- <8.5 Dual combination therapy 1 (3.4) 2(6.9)
8.5- 10 Triple combination therapy 0 (0) 7 (24.1)
>10.0
Combination therapy + 
insulin
0 (0) 3 (10.3)
Total 13 (44.8) 16 (55.2)
CPG= Clinical Practice guidelines, $- patients were already started on therapy and as per CPG 
guidelines, if HbA1c < 6.5 to continue treatment
Table VII: Correlation Between HbA1 Control, Age and BMI
HbA1c control (%)
Correlation coefficient, r P value
Age
BMI
-0.117
0.250
0.546
0.190
*Pearson’s correlation test
Table VI: Association of Treatment According to the Malaysian CPG 
with Diabetic Control#
Adherence 
to guidelines
Frequency
(N= 29)
DM control (N= 29) X2 (df)
P value#
Controlled Uncontrolled
Yes 13 12 (92.3) 1 (7.7)
13.14 
(1) 0.002*
No 16 4 (25) 12 (75)
CPG= Clinical Practice guidelines, #=Fisher exact test
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healthcare professionals and students, and the funding 
for the clinic needs are mainly by donation.  Donations 
include in the form of the medications that are supplied 
free of charge to the clinic, or when the volunteers 
purchased the drug stock according to the needs and 
drug supply level of the clinic. 
A total of 29 patients were included in this study.  The 
majority of the T2DM patients at the mobile clinic 
are females. This is similar to a study among adults in 
Vietnam that showed that women are more likely to 
have T2DM than men (4). Another study done among 
refugees also stated that majority of patients with 
chronic disease are females because many of their male 
counterparts were killed  during the violence clashes as 
described earlier(5). The majority of the patients with 
DM at the mobile clinic are aged below 65 years old. 
This concurs with another study done among Myanmar 
refugees that stated that the majority of them are young 
adults in the age group of 20-45 years old (6). 
The majority of patients have HbA1c of less than 
6.5%,that clearly indicates that the treatment provided 
at the clinic has helped to improve the glycaemic 
control among the refugees with T2DM. Rather 
unsurprisingly, we found that the majority of the T2DM 
patients were obese and overweight. This is also seen 
as a common phenomenon in both the refugee and 
non-refugee population as supported by a study done 
among refugee psychiatric patients that showed an 
increase in percentage of diabetes and hypertension 
with increasing BMI (5). Nevertheless, we found no 
significant correlation between patient’s age and BMI 
and their HbA1c levels. 
This study mainly looked at the drug prescribing pattern 
by the volunteer doctors and compared them to the local 
guidelines.  Prior to 2018, when there were no official 
volunteers list, the volunteer recruitment was handled 
by appointed IMARET staff. Prior to holding the clinics, 
message on the need of volunteer doctors and healthcare 
professionals were shared via social media. There are at 
least two fully registered doctors in each clinic session, 
and the rest were support staffs. The qualifications of the 
doctors that volunteered for these clinics were verified 
by their annual practice certificate (APC) numbers. They 
were mainly medical officers working in government 
health facilities and are not necessarily practicing in the 
primary care level. Sometimes, specialists would also 
volunteer their service to this noble cause. 
The treatment available are based on public and 
corporate funding. The oral hypoglycemic agents 
available are metformin 500mg, glibenclamide 5mg 
and gliclazide 80mg. The staff in charge will check that 
the medication supplies are sufficient prior to the clinic 
sessions. If not, it will be purchased with the donated 
funds. Sometimes, there are donation of certain types of 
medication such as metformin XR in which the IMARET 
exco in charge of the clinic will screen first on its need 
and use in the clinic, and then decide whether to accept 
or decline this free supply. For example, insulin is not 
accepted due to storage and language barrier reasons. 
The patients will be prescribed whatever is available 
during their follow up. Patients are usually given follow 
up in a month regardless, as the medications are only 
given for a maximum of one month. 
Metformin was the most frequently prescribed anti-
diabetic agent at the mobile clinic. This was not 
unexpected as according to Malaysian CPG Management 
of T2DM, metformin would be the preferred choice as 
a first line therapy. Furthermore, if  the use of metformin 
is not contraindicated, it is the preferred and a cost-
effective agent when used as the initial drug therapy 
for T2DM (7). This study found that metformin use as 
a monotherapy and also in  combination therapy were 
the most commonly prescribed treatment regimen 
which was also reflected in a previous study done in an 
outpatient care setting (8). However, the prescription of 
combined therapy involving metformin and gliclazide 
are more common in this study as opposed to the usual 
combination of metformin and glibenclamide, which 
is in contrast with a study done in an outpatient clinic 
setting in Nigeria (9). Understandably, the combination of 
metformin and gliclazide is more preferred as gliclazide 
causes less risk of hypoglycemia as compared to the 
older generation sulphonylureas such as glibenclamide 
(12).
Targets for each patients’ HbA1c levels were 
individualised according to the patient’s overall clinical 
profile based on the Malaysian CPG on the management 
of T2DM. Factors taken into consideration included 
the patient’s co-morbidities, age, duration of illness 
and the risk of hypoglycemia (10, 12). We found that 
the percentage of patients in each target groups were 
similar which was around 30%. In terms of achieving 
the recommended glucose control, this study found that 
37.9% of the patients did not achieve their target HbA1c 
level. It is also noted that a high 62.8% of the treatment 
prescribed were not adhering to the Malaysian type 2 
diabetes mellitus CPG. One of the main reasons identified 
were because there were no insulin therapy available to 
be dispensed for the patients. The mobile clinic does not 
stock up insulin supply due to the extra measures needed 
to store, along with the cost implications, and also the 
problem of language barrier faced by the volunteers 
that may cause difficulties in educating the patients on 
correct insulin injection techniques. Another reason for 
patients not achieving the target glycemic levels is due 
to the lack of therapy intensification by the healthcare 
provider (i.e physician’s inertia). An earlier study had 
suggested that one of the primary factors contributing to 
the failure of the patients with DM to achieve glycemic 
control is due to lack of appropriate intensification of 
medication therapy by the healthcare provider, which 
may also be the case in this study (14). The adherence 
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to the recommended treatment prescribed according 
to the CPG guidelines and DM control of patients in 
this study showed significant association (p=0.02). 
The patients who received treatment that followed the 
recommendations of the guidelines have a higher odd 
of having a good glycaemic control as compared to 
those who received treatment that did not adhere to the 
guidelines. 
Nevertheless, there are also many other factors affecting 
the optimization of treatment among patients with 
T2DM and this has been studied in great detail in 
previous studies. Among the issues that are important 
and may affect the control of this condition is adherence 
to treatment, diabetic self-care, diabetic self-efficacy 
and social support (14-16). This is however, not within 
the scope of this study, mainly due to the limited time 
and the problem faced in term of language barrier. 
There is not denying that they are many challenges in 
providing healthcare to refugees. These includes the lack 
of knowledge and access to basic health care in addition 
to the fear of risk of arrest and limited opportunity for 
education among this marginalized community (17,18). 
Because they are not Malaysian citizens, in order 
to receive medical care, they often need to pay for 
treatment. The cost of healthcare is a burden to them, 
and as most of them are unemployed, they are often 
unable to pay for the medical fees. Their refugee status 
prevents them from working legally, hence the vicious 
cycle continues. Although many agencies are providing 
financial aid to those with refugee status, the procedure 
of being registered legally under United Nations High 
Commissioner for Refugees (UNCHR) is a long and 
tedious process. This leaves many loopholes for the 
people of Rohingya origin in order to seek their basic 
human right for quality healthcare. There are many non-
governmental organizations (NGO) that are taking steps 
to help these unfortunate community and among them 
is the setting up of mobile clinics similar to our study 
to help ease some of their burden. This includes the 
services provided by the UNCHR including registration 
and providence of UNCHR card which enables certain 
useful benefits such as rebate for the cost of health care 
at government health facilities (18). However, there is 
still a big number of refugees with health problems that 
are often left neglected. We hope that this article can 
raise awareness on this issue and therefore, more steps 
are taken towards the wellbeing of this marginalised 
group. 
Steps that can be taken by medical NGO’s such as 
IMARET includes among other, to continue doing their 
monitoring of treatment for refugees, and to educate the 
volunteer doctors on the proper management on chronic 
diseases such as T2DM. Other steps that can be taken is 
finding the right volunteers to run the clinics, especially 
those who are working in the primary care setting. This 
itself poses as a big challenge as IMARET cannot be too 
choosy when it comes to manpower due to the lack of 
willing volunteers. Provision of a high-quality culture 
sensitive healthcare services to the refugees can be both 
fulfilling and challenging (17). To be able to provide 
this kind of services, primary care physicians should 
be the front liner as they are most of the time able to 
understand the physical and psycho-social problems 
faced by this special group of the population. This will 
in a way call for more training on refugees’ healthcare 
needs including addressing issues of mental health 
(19). A study in Sweden among refugees revealed that 
the quality of health care provision to this group was 
similar as to non-refugees (20). However, what is most 
often desired by this marginalised group was provision 
of more information about their medical problem and a 
feeling of a sense of caring by the health professionals 
(20).  Therefore, this reiterate the call for more training 
in this aspect of health services. Alas, a developed 
society’s moral standard will be determined by how its 
most vulnerable citizens are treated (17). Also, equally 
important is the need to have a high index of suspicion 
to diagnose DM in those with atypical presentation such 
as lethargy and genital infection as to not missed out on 
this important diagnosis (21).
 
To our knowledge this is first study of its kind among 
Rohingya patients with T2DM in Malaysia. Nevertheless, 
we are aware of the limitations of this study in which is 
only a small group of patients were recruited due to the 
limited time of this study. This study was only done in the 
state of Selangor by a single NGO and may not reflect 
the findings of other similar populations elsewhere in 
Malaysia. We realise that this study only takes into 
consideration the prescribed medications and does 
not explore other issues such as patient’s knowledge, 
adherence, diabetes self-care and self-efficacy. We 
would recommend a bigger, nationwide study involving 
more NGOs that provide the same services in order to 
get a larger pool of patients to confirm the findings of 
this study. 
CONCLUSION
In Rohingya refugees with T2DM treated in the IMARET 
mobile clinics, the percentage of controlled DM status 
is higher in those that had their treatment regimen 
adhering to the clinical practice guidelines. Therefore, 
interventions should be offered according to the 
recommendations by the guidelines while considering 
all the limitations that are usually encountered atsuch 
mobile clinics. The treatment of DM offered to 
refugees in the IMARET mobile clinic still needs much 
improvement. More funds and support will go a long 
way to the improve the scope of services offered by this 
noble initiative.
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